FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549  

Report of Foreign Private Issuer 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934 

For the month of February, 2020

Commission File Number: 001-38562

NEW FRONTIER HEALTH CORPORATION 
(Translation of Registrant’s Name into English)

10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015,
Beijing, China
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x             Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes ¨             No x

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes ¨             No x

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Attached as Exhibit 99.1 hereto is a presentation that representatives of New Frontier Health Corporation plan to use with investors.

EXHIBIT INDEX

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 19, 2020